Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 44,498 | 22,791 | 11,147 | 0 |
| Operating Income | -44,498 | -22,791 | -11,147 | N/A |
| Other Income | 1,365 | 80 | 93 | 0 |
| Pre-tax Income | -43,133 | -22,711 | -11,054 | 0 |
| Net Income Continuous | -43,133 | -22,711 | -11,054 | N/A |
| Net Income | $-43,133 | $-22,711 | $-11,054 | $N/A |
| EPS Basic Total Ops | -4.80 | -51.84 | -25.24 | N/A |
| EPS Basic Continuous Ops | -4.80 | -51.85 | -25.24 | N/A |
| EPS Diluted Total Ops | -4.80 | -51.84 | -25.24 | N/A |
| EPS Diluted Continuous Ops | -4.80 | -51.85 | -25.24 | N/A |
| EPS Diluted Before Non-Recurring Items | -4.80 | N/A | N/A | N/A |
| EBITDA(a) | $-44,207 | $-22,513 | $-10,986 | $N/A |